Global reach Euroimmun operates in over 140 countries with a large installed base of laboratories, hospitals, health authorities, and academic institutions, presenting opportunities to cross-sell test systems, software, and automation solutions to existing customers and expand into new regions.

Diagnostics ecosystem As a leading medical laboratory diagnostics manufacturer offering test systems, software, and automation, Euroimmun can be pursued for integrated solutions that streamline workflows, data management, and result interpretation across autoimmune and infectious disease testing.

Tech enablement Adoption of modern tech stack tools such as Databricks, Power BI, Terraform, Jenkins, Boomi and other platforms indicates openness to data analytics, automation, and cloud-based workflows, suggesting opportunities for advanced analytics services, platform integrations, and managed services.

Growth potential With revenue in the mid single to mid double digits of millions and a sizable global footprint, there is room to upsell higher-tier monitoring, quality assurance software, and scalable automation solutions to improve throughput and compliance for laboratories.

Strategic partnerships Recent activity in infectious disease diagnostics and collaboration with broader diagnostics ecosystems point to potential co-development, distribution partnerships, or joint ventures with complementary players to expand market share and accelerate time-to-value for customers.